Impact Biomedical Inc. Announcement Stock Activity/Pricing

Rhea-AI Summary

Impact BioMedical (NYSE American: IBO) released a statement on March 21, 2025, addressing unusual market activity in its stock price. The company confirmed that there have been no material developments in its business operations beyond what has been previously disclosed to the public. The biotechnology company, which focuses on discovering, developing, and patenting innovative healthcare solutions, stated it is unaware of any other reasons that could explain the unusual trading activity in its shares.

HOUSTON, March 21, 2025 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative healthcare solutions, today announced that there has been no material development in its business affairs not previously disclosed or, to its knowledge, any other reason to account for the unusual market action regarding its share price.

About Impact BioMedical, Inc.:

Impact BioMedical Inc. (NYSE American: IBO) discovers, confirms, and patents unique science and technologies which can be developed into new offerings in biopharmaceuticals and consumer healthcare and wellness in collaboration with external partners through research, licensing, co-development, joint ventures, and other relationships.

Safe Harbor Disclosure:

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are subject to risks and uncertainties that may cause actual results or events to differ materially from those projected. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date.

Investor Relations:
info@impactbiomedinc.com

www.impactbiomedinc.com

FAQ

What caused the unusual stock price movement in Impact BioMedical (IBO) shares on March 21, 2025?

According to the company's statement, there were no undisclosed material developments or known reasons to explain the unusual market activity.

Has Impact BioMedical (IBO) disclosed any new business developments as of March 21, 2025?

No, the company confirmed there were no new material business developments beyond what was previously disclosed.

What was Impact BioMedical's (IBO) response to the unusual trading activity?

The company issued a statement confirming no undisclosed material developments and no known reasons for the unusual market action.

Did Impact BioMedical (IBO) announce any changes to its business operations on March 21, 2025?

No, the company stated there were no material changes to its business operations beyond previously disclosed information.